Commentary

Page 2

Posts about this type

JCP
Defining and Achieving Treatment Recovery in Schizophrenia
Commentary

January 18, 2023

This article defines treatment recovery in schizophrenia and summarizes strategies clinicians can pursue to improve patient outcomes.
Dawn I. Velligan, Sanjai Rao
JCP
Actualizing and Sustaining Recovery-Oriented Care
Commentary

January 16, 2023

Jack Tsai, PhD, comments on intensity of therapy and scalability issues in a recent study of the Opening Doors to Recovery program for SMI.
Jack Tsai
JCP
Recent Advances in Screening for Mild Cognitive Impairment and Alzheimer Disease
Commentary

December 26, 2022

Among the most transformative Alzheimer disease discoveries is the existence of biomarkers which can manifest decades before onset of disease-related dementia.
Allan Anderson, Matthew Malone
JCP
The Differential Diagnosis and Treatment of Mild Cognitive Impairment and Alzheimer Disease
Commentary

December 26, 2022

Navigating the associated differential diagnosis in AD is essential as various causes of cognitive impairment require different treatment strategies.
Allan Anderson, Matthew Malone
JCP
Developing Mental Illness Stigma–Reducing Interventions
Commentary

December 19, 2022

Research on antistigma interventions needs to look at sustained changes in attitudes and knowledge over time.
Aderonke Bamgbose Pederson
PCC
An Update on the Future of Wilson Disease Management
Commentary

November 29, 2022

Due to Wilson disease myriad manifestations, its rarity, and its range of symptoms, differential diagnosis may be challenging, leading to delays in treatment. This Neuroscience Commentary reviews diagnostic acumen...
Robert S. Brown, Jr
JCP
Bipolar Disorder and PMDD: Comorbidity Conundrum
Commentary

October 26, 2022

Teri Pearlstein, MD, discusses a recent review that highlights the difficulties of diagnosing PMDD in women with bipolar disorder.
Teri Pearlstein
JCP
Relationship Between MDD and Medical Conditions
Commentary

October 19, 2022

This commentary by Rachel A. Weir, MD, and Mark Hyman Rapaport, MD, discusses the article by Alix M. Arnaud, MSc, and colleagues on the overlap between major depressive disorder...
Rachel A. Weir, Mark Hyman Rapaport
JCP
Lost in Translation: The Value of Psychiatric Clinical Trials
Commentary

October 17, 2022

John C. Markowitz, MD, and Barbara L. Milrod, MD, assert the value of clinical trials in psychiatry and outline reasons why NIMH should resume supporting them.
John C. Markowitz, Barbara L. Milrod
JCP
Ketamine in the Real World: Where Do We Go From Here?
Commentary

September 14, 2022

Dr Wilkinson comments on recent data and developments in the use of ketamine for mood disorders.
Samuel T. Wilkinson
JCP
Positive Predictive Value
Commentary

August 24, 2022

In this Commentary, the author posits that knowledge about positive predictive value—the probability a person identified as ill by a screening test does indeed have the illness—is important for...
Mark Zimmerman
JCP
Psychiatric Care Considerations for Sexually and Gender Diverse Populations
Commentary

July 18, 2022

Dr Keuroghlian discusses recent research by Oka et al on LGBTQ patients’ clinical characteristics and response to ECT.
Alex S. Keuroghlian
JCP
Accumulation of Reproductive Safety Data for SGAs
Commentary

June 8, 2022

This commentary on an article by Yakuwa and colleagues calls for an acceleration of the acquisition of clinical data on the safety of second-generation antipsychotics for pregnant women and...
Adele C. Viguera
JCP
Should Blind Psychiatrists Be Paid Less?
Commentary

May 23, 2022

Dr Zimmerman comments on a recent meta-analysis by Scott and colleagues on the use of video-based telehealth in treatment of PTSD.
Mark Zimmerman, MD
PCC
Gandhian Concepts on Mental Health in Contemporary COVID-19 Pandemic Times
Commentary

April 19, 2022

In this commentary, the authors discuss Gandhi’s views on mental health, especially in the context of the COVID-19 pandemic.
Gurvinder Pal Singh, Gulbahar Sidhu, Deepali Gul, et al
PCC
US Suicide Rates and Impact of Major Disasters
Commentary

April 12, 2022

This commentary explores the impact of major disasters on suicide rates, especially in the context of the COVID-19 pandemic.
Tarun Bastiampillai, Stephen Allison, Janel Cubbage, et al
JCP
What Is the Role of Digital Medicine for Adherence Monitoring in Patients With SMI?
Commentary

April 11, 2022

This commentary looks at the benefits and limitations of digital medicine systems and discusses a recent trial in schizophrenia patients by Cohen et al.
Oliver Freudenreich
JCP
Functional Outcomes of an Antipsychotic in Schizophrenia: Generalizable or Specific Effect?
Commentary

March 1, 2022

This commentary takes a closer look at Correll and colleagues’ findings on functional outcomes with brexpiprazole.
Nina R. Schooler
PCC
Commentary

January 20, 2022

In this commentary, the authors discuss biological similarities of the opioid epidemic and the COVID-19 pandemic, as well as differences in response to the 2 public health crises.
Akshay P. Padala, Kerrie B. Wilson, Aparna Das
PCC
Commentary

January 20, 2022

Patients with psychiatric disorders may be at greater risk of experiencing adverse outcomes from COVID-19. Read on to find out more.
Ramu Vadukapuram, Chintan Trivedi, Zeeshan Mansuri
JCP
Commentary

January 18, 2022

This commentary discusses the article by Zeifman and colleagues on the role classic psychedelic agents may have in reducing risk of suicide.
Daniel H. Grossman, Peter S. Hendricks
JCP
Commentary

January 4, 2022

This commentary discusses the review by Vaccarino and colleagues of cognitive effects associated with ketamine treatment for major depressive disorder.
Joseph F. Goldberg
PCC
Commentary

December 16, 2021

In this commentary, the authors discuss the new Omicron variant of COVID-19 as well as the potential mental health challenges that will likely unfold over the next year.
Ankit Jain, Taranjeet S. Jolly
PCC
Commentary

November 18, 2021

There are signs that the COVID-19 pandemic may disproportionately impact suicide rates among Black and other vulnerable populations in the US. This commentary explores this possibility in the context...
Tarun Bastiampillai, Stephen Allison, Jeffrey C. L. Looi

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe